{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T01:33:45Z","timestamp":1784252025560,"version":"3.55.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["ICMR IIRP-2023-6091"],"award-info":[{"award-number":["ICMR IIRP-2023-6091"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010476","name":"Tata Memorial Centre","doi-asserted-by":"publisher","award":["TRAC\/1222\/900871\/01"],"award-info":[{"award-number":["TRAC\/1222\/900871\/01"]}],"id":[{"id":"10.13039\/501100010476","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemistry and Biophysics Reports"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.bbrep.2025.101987","type":"journal-article","created":{"date-parts":[[2025,4,6]],"date-time":"2025-04-06T17:45:06Z","timestamp":1743961506000},"page":"101987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["\u2018Nelfinavir sensitizes a clinically relevant chemo-radioresistant cervical cancer in-vitro model by targeting the AKT-USP15\/USP11-HPV16 E6\/E7 axis"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8270-6731","authenticated-orcid":false,"given":"Reshma","family":"Reddy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vagmi","family":"Gaiwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayant Sastri","family":"Goda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3229-4296","authenticated-orcid":false,"given":"Tanuja","family":"Teni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrep.2025.101987_bib1","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbrep.2025.101987_bib2","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1200\/GO.20.00122","article-title":"Cancer statistics, 2020: report from national cancer registry programme, India","author":"Mathur","year":"2020","journal-title":"JCO Global Oncology"},{"key":"10.1016\/j.bbrep.2025.101987_bib3","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S0140-6736(13)60022-7","article-title":"Human papillomavirus and cervical cancer","volume":"382","author":"Crosbie","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.bbrep.2025.101987_bib4","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/ijc.IJC_428_17","article-title":"Locally advanced cervical cancer: a study of 5-year outcomes","volume":"55","author":"Chopra","year":"2018","journal-title":"Indian J. Cancer"},{"key":"10.1016\/j.bbrep.2025.101987_bib5","first-page":"1","article-title":"Patterns of first relapse and outcome in patients with locally advanced cervical cancer after radiochemotherapy: a single institutional experience","volume":"1","author":"Sasidharan","year":"2019","journal-title":"Indian Journal of Gynecologic Oncology"},{"key":"10.1016\/j.bbrep.2025.101987_bib6","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1158\/1078-0432.CCR-15-2322","article-title":"Integrative analysis of DCE-MRI and gene expression profiles in construction of a gene classifier for assessment of hypoxia-related risk of chemoradiotherapy failure in cervical cancer","volume":"22","author":"Fjeldbo","year":"2016","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrep.2025.101987_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4103\/ijmr.IJMR_1939_16","article-title":"Chemoradiation therapy induces in vivo changes in gene promoter methylation & gene transcript expression in patients with invasive cervical cancer","volume":"147","author":"Sood","year":"2018","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.bbrep.2025.101987_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.adcanc.2022.100074","article-title":"Insights into therapy resistance in cervical cancer","volume":"6","author":"George","year":"2022","journal-title":"Advances in Cancer Biology - Metastasis"},{"key":"10.1016\/j.bbrep.2025.101987_bib9","doi-asserted-by":"crossref","first-page":"1885","DOI":"10.2147\/DDDT.S106412","article-title":"Molecular mechanisms of cisplatin resistance in cervical cancer","volume":"10","author":"Zhu","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.bbrep.2025.101987_bib10","doi-asserted-by":"crossref","first-page":"582","DOI":"10.3390\/cancers12030582","article-title":"Radiosensitization by hyperthermia: the effects of temperature, sequence, and time interval in cervical cell lines","volume":"12","author":"Mei","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bbrep.2025.101987_bib11","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(24)00317-9","article-title":"Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11\/GOG-3047\/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial","volume":"403","author":"Lorusso","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.bbrep.2025.101987_bib12","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1136\/ijgc-2022-003585","article-title":"Drug repurposing as a potential source of innovative therapies in cervical cancer","volume":"32","author":"Capistrano","year":"2022","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.bbrep.2025.101987_bib13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.pvr.2017.12.006","article-title":"Therapeutic vaccines for high-risk HPV-associated diseases","volume":"5","author":"Chabeda","year":"2017","journal-title":"Papillomavirus Res"},{"key":"10.1016\/j.bbrep.2025.101987_bib14","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1186\/s12913-022-08272-z","article-title":"Drug repurposing: a systematic review on root causes, barriers and facilitators","volume":"22","author":"Krishnamurthy","year":"2022","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.bbrep.2025.101987_bib15","doi-asserted-by":"crossref","first-page":"3437","DOI":"10.3390\/cancers12113437","article-title":"The anti-cancer properties of the HIV protease inhibitor nelfinavir","volume":"12","author":"Subeha","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.bbrep.2025.101987_bib16","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3181\/00379727-135-35091a","article-title":"Studies on a new human cell line (SiHa) derived from carcinoma of uterus. I. Its establishment and morphology","volume":"135","author":"Friedl","year":"1970","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.bbrep.2025.101987_bib17","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/ijc.24999","article-title":"Cell line cross-contamination initiative: an interactive reference database of STR profiles covering common cancer cell lines","volume":"126","author":"Dirks","year":"2010","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrep.2025.101987_bib18","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s41416-021-01421-x","article-title":"Elevated USP9X drives early-to-late-stage oral tumorigenesis via stabilisation of anti-apoptotic MCL-1 protein and impacts outcome in oral cancers","volume":"125","author":"Sulkshane","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bbrep.2025.101987_bib19","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.ygyno.2017.11.034","article-title":"Impact of HPV 16\/18 infection on clinical outcomes in locally advanced cervical cancers treated with radical radio (chemo) therapy - a prospective observational study","volume":"148","author":"Mahantshetty","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbrep.2025.101987_bib20","doi-asserted-by":"crossref","first-page":"8885","DOI":"10.1128\/JVI.00605-09","article-title":"The ubiquitin-specific peptidase USP15 regulates human papillomavirus type 16 E6 protein stability","volume":"83","author":"Vos","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.bbrep.2025.101987_bib21","doi-asserted-by":"crossref","first-page":"15681","DOI":"10.1074\/jbc.M708278200","article-title":"USP11 stabilizes HPV-16E7 and further modulates the E7 biological activity","volume":"283","author":"Lin","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrep.2025.101987_bib22","article-title":"Cervical cancer prognosis and related risk factors for patients with cervical cancer: a long-term retrospective cohort study","volume":"12","author":"Li","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrep.2025.101987_bib23","doi-asserted-by":"crossref","first-page":"842","DOI":"10.20892\/j.issn.2095-3941.2020.0005","article-title":"Adaptive response of resistant cancer cells to chemotherapy","volume":"17","author":"Chern","year":"2020","journal-title":"Cancer Biol Med"},{"key":"10.1016\/j.bbrep.2025.101987_bib24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s13046-020-01737-1","article-title":"Targeting HMGB3\/hTERT axis for radioresistance in cervical cancer","volume":"39","author":"Li","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbrep.2025.101987_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.592706","article-title":"Pentoxifylline sensitizes cisplatin-resistant human cervical cancer cells to cisplatin treatment: involvement of mitochondrial and NF-kappa B pathways","volume":"10","author":"Bravo-Cuellar","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbrep.2025.101987_bib26","first-page":"151","article-title":"[Establishment of a cisplatin-resistant human cervical cancer cell line]","volume":"43","author":"Chen","year":"2012","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"10.1016\/j.bbrep.2025.101987_bib27","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2407-10-71","article-title":"Microarray analysis of DNA damage repair gene expression profiles in cervical cancer cells radioresistant to 252Cf neutron and X-rays","volume":"10","author":"Qing","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbrep.2025.101987_bib28","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1002\/path.1706","article-title":"Molecular mechanisms of drug resistance","volume":"205","author":"Longley","year":"2005","journal-title":"J. Pathol."},{"key":"10.1016\/j.bbrep.2025.101987_bib29","article-title":"Human papillomavirus E6 and E7: what remains? Tumour","volume":"11","author":"Vats","year":"2021","journal-title":"Virus Res."},{"key":"10.1016\/j.bbrep.2025.101987_bib30","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1096\/fj.00-0728fje","article-title":"The HPV16 E6 and E7 proteins and the radiation resistance of cervical carcinoma","volume":"15","author":"Hampson","year":"2001","journal-title":"FASEB j."},{"key":"10.1016\/j.bbrep.2025.101987_bib31","doi-asserted-by":"crossref","first-page":"6711","DOI":"10.2147\/OTT.S205334","article-title":"Inhibiting the HPV16 oncogene-mediated glycolysis sensitizes human cervical carcinoma cells to 5-fluorouracil","volume":"12","author":"Ma","year":"2019","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.bbrep.2025.101987_bib32","doi-asserted-by":"crossref","first-page":"12243","DOI":"10.3390\/ijms160612243","article-title":"Human papillomavirus E6\/E7-specific siRNA potentiates the effect of radiotherapy for cervical cancer in vitro and in vivo","volume":"16","author":"Jung","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrep.2025.101987_bib33","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.1038\/s41598-019-42393-6","article-title":"Comparative RNA sequencing reveals that HPV16 E6 abrogates the effect of E6\u2217I on ROS metabolism","volume":"9","author":"Paget-Bailly","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrep.2025.101987_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2174\/1874357900802010015","article-title":"Different isoforms of HPV-16 E7 protein are present in cytoplasm and nucleus","volume":"2","author":"Valdovinos-Torres","year":"2008","journal-title":"Open Virol. J."},{"key":"10.1016\/j.bbrep.2025.101987_bib35","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1002\/ijc.32793","article-title":"Decreased local immune response and retained HPV gene expression during chemoradiotherapy are associated with treatment resistance and death from cervical cancer","volume":"146","author":"Cosper","year":"2020","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.bbrep.2025.101987_bib36","doi-asserted-by":"crossref","first-page":"5183","DOI":"10.1158\/1078-0432.CCR-07-0161","article-title":"Nelfinavir, A lead HIV protease inhibitor, is a broad-spectrum, anticancer agent that induces endoplasmic reticulum stress, autophagy, and apoptosis in vitro and in vivo","volume":"13","author":"Gills","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrep.2025.101987_bib37","first-page":"1837","article-title":"Nelfinavir is effective against human cervical cancer cells in vivo: a potential treatment modality in resource-limited settings","volume":"10","author":"Davis","year":"2016","journal-title":"Drug Des. Dev. Ther."},{"key":"10.1016\/j.bbrep.2025.101987_bib38","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1002\/cncr.30667","article-title":"Cervical cancer: a global health crisis","volume":"123","author":"Small","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.bbrep.2025.101987_bib39","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1593\/neo.07124","article-title":"The HIV protease inhibitor nelfinavir downregulates Akt phosphorylation by inhibiting proteasomal activity and inducing the unfolded protein response","volume":"9","author":"Gupta","year":"2007","journal-title":"Neoplasia"},{"key":"10.1016\/j.bbrep.2025.101987_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155970","article-title":"Oxidative stress mediates the antiproliferative effects of nelfinavir in breast cancer cells","volume":"11","author":"Soprano","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.bbrep.2025.101987_bib41","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1038\/onc.2016.424","article-title":"TGF-\u03b2 upregulates the translation of USP15 via the PI3K\/AKT pathway to promote p53 stability","volume":"36","author":"Liu","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrep.2025.101987_bib42","doi-asserted-by":"crossref","first-page":"13813","DOI":"10.1111\/jcmm.15971","article-title":"USP15 promotes the apoptosis of degenerative nucleus pulposus cells by suppressing the PI3K\/AKT signalling pathway","volume":"24","author":"Yu","year":"2020","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.bbrep.2025.101987_bib43","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3390\/cancers15051371","article-title":"USP15 represses hepatocellular carcinoma progression by regulation of pathways of cell proliferation and cell migration: a system biology analysis","volume":"15","author":"Ren","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.bbrep.2025.101987_bib44","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41388-023-02847-8","article-title":"USP11 potentiates HGF\/AKT signaling and drives metastasis in hepatocellular carcinoma","volume":"43","author":"Chen","year":"2024","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrep.2025.101987_bib45","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/s41467-019-08481-x","article-title":"PTEN self-regulates through USP11 via the PI3K-FOXO pathway to stabilize tumor suppression","volume":"10","author":"Park","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrep.2025.101987_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2023.148321","article-title":"USP11 exacerbates neuronal apoptosis after traumatic brain injury via PKM2-mediated PI3K\/AKT signaling pathway","volume":"1807","author":"Fang","year":"2023","journal-title":"Brain Res."},{"key":"10.1016\/j.bbrep.2025.101987_bib47","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3390\/pathogens9020133","article-title":"HPV oncoproteins and the ubiquitin proteasome system: a signature of malignancy?","volume":"9","author":"\u0110uki\u0107","year":"2020","journal-title":"Pathogens"},{"key":"10.1016\/j.bbrep.2025.101987_bib48","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3390\/cancers13050949","article-title":"HIV-1 protease inhibitors slow HPV16-driven cell proliferation through targeted depletion of viral E6 and E7 oncoproteins","volume":"13","author":"Park","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.bbrep.2025.101987_bib49","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1038\/onc.2011.443","article-title":"Deubiquitinases in cancer: new functions and therapeutic options","volume":"31","author":"Fraile","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrep.2025.101987_bib50","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1002\/cncr.33449","article-title":"Phase 1 trial of nelfinavir added to standard cisplatin chemotherapy with concurrent pelvic radiation for locally advanced cervical cancer","volume":"127","author":"Garcia\u2010Soto","year":"2021","journal-title":"Cancer."},{"key":"10.1016\/j.bbrep.2025.101987_bib51","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-055765","article-title":"Concurrent chemoradiation and brachytherapy alone or in combination with nelfinavir in locally advanced cervical cancer (NELCER): study protocol for a phase III trial","volume":"12","author":"Chopra","year":"2022","journal-title":"BMJ Open"}],"container-title":["Biochemistry and Biophysics Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825000743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405580825000743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T17:33:54Z","timestamp":1762623234000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405580825000743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":51,"alternative-id":["S2405580825000743"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.101987","relation":{},"ISSN":["2405-5808"],"issn-type":[{"value":"2405-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u2018Nelfinavir sensitizes a clinically relevant chemo-radioresistant cervical cancer in-vitro model by targeting the AKT-USP15\/USP11-HPV16 E6\/E7 axis","name":"articletitle","label":"Article Title"},{"value":"Biochemistry and Biophysics Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrep.2025.101987","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101987"}}